Results 221 to 230 of about 134,929 (355)

From 5F hematopoietic progenitors to osteoclasts: a scalable human model of osteoclastogenesis. [PDF]

Front Cell Dev Biol
Malayaperumal S, Stewart S, Wellington R, Doulatov S, Leber E, Scatena M, Blümke A, Giachelli CM.   +7 more
europepmc   +1 more source

osteoclast

Citation: 'osteoclast' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.11050 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Study of the Mechanism of Action of Deer Bone Water Extract Fermented by <i>Lactobacillus reuteri</i> on Rheumatoid Arthritis-Induced Osteoporosis. [PDF]

Nutrients
Jiang Y, Wei X, Yan J, Xing Y, Li Y, Li A, Teng Y, Ren T, Chen W, Li J, Zong Y, Du R.   +11 more
europepmc   +1 more source

Cancer pain: current practice and emerging targets

British Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye, Marcin Chwistek, Zhiting Gong, Vanessa Uzonwanne, Xiaojie Shi, Arpad Szallasi   +5 more
wiley   +1 more source

Regenerative bone-targeted nanoparticles modulate osteoclast function.

Nanoscale Horiz
Rangasami VK, Moore CJ, Xiao B, Benoit DSW.   +3 more
europepmc   +1 more source

Beyond resorption-driven coupling: a multi-layered framework for osteoclast-osteoblast communication and its therapeutic consequences. [PDF]

Front Endocrinol (Lausanne)
Qiu H, Liu S, Jiang Y, Lai Y, Lin Q, Huang A.   +5 more
europepmc   +1 more source

Osteoclasts: what do they do and how do they do it?

American Journal of Pathology, 2007
S. Teitelbaum
semanticscholar   +1 more source

Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular Insights

Cancer Science, EarlyView.
Schematic overview of progression from differentiated thyroid carcinoma (DTC) to anaplastic thyroid carcinoma (ATC). ATC primarily develops via two pathways: the BRAF p.V600E‐mutated papillary thyroid carcinoma (PTC) pathway and the RAS‐mutated pathway. The origin and progression of BRAF/RAS‐wildtype ATC remain unclear.
Toru Odate, Tetsuo Kondo
wiley   +1 more source

Macrophage polarization regulates bone homeostasis: a potential etiology and therapy for postmenopausal osteoporosis. [PDF]

Front Immunol
Danzeng Q, Wu F, Cui M, Shen Y, Li Y, Jiao J, Jiang W.   +6 more
europepmc   +1 more source